h-Lys-leu-val-phe-phe-oh

H-Lys-Leu-Val-Phe-Phe-OH combines hydrophobic and aromatic residues with a basic N-terminal lysine that modulates solubility and binding. The sequence supports investigations of π-stacking and hydrophobic packing. Researchers explore its folding preferences in solution. Use extends to motif analysis, peptide design, and binding-model studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
h-Lys-leu-val-phe-phe-oh(CAS 153247-40-6)

CAT No: R2448

CAS No:153247-40-6

Synonyms/Alias:h-lys-leu-val-phe-phe-oh;153247-40-6;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid;Amyloid b-Protein (16-20);Lys-Leu-Val-Phe-Phe;L-Phenylalanine,L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-;HY-P5124;FA109060;CS-0774329;Amyloid beta-Protein (16-20) trifluoroacetate salt;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C35H52N6O6
M.W/Mr.
652.8
Sequence
One Letter Code:KLVFF
Three Letter Code:H-Lys-Leu-Val-Phe-Phe-OH
InChI
InChI=1S/C35H52N6O6/c1-22(2)19-27(38-31(42)26(37)17-11-12-18-36)33(44)41-30(23(3)4)34(45)39-28(20-24-13-7-5-8-14-24)32(43)40-29(35(46)47)21-25-15-9-6-10-16-25/h5-10,13-16,22-23,26-30H,11-12,17-21,36-37H2,1-4H3,(H,38,42)(H,39,45)(H,40,43)(H,41,44)(H,46,47)/t26-,27-,28-,29-,30-/m0/s1
InChI Key
SICITCLFXRGKJW-IIZANFQQSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide CDMOcGMP Peptide ServiceEpitope Mapping ServicesPeptide Modification ServicesPeptide Synthesis ServicesPeptide Analysis ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers